LKT Laboratories, Inc.

LKT Laboratories, Inc. logo

LKT Laboratories, Inc. is a research and development company focused on the discovery of specialty chemicals for cancer chemoprevention. We produce and distribute unique chemicals and biochemicals for all types of life science research and supply raw materials for manufacturing and repacking.

Company Website

Product Listing

Clofarabine 10 mg  | ≥98%

LKT Laboratories, Inc.

Nucleoside (adenosine) analog; DNA chain terminator, ribonucleotide reductase and DNA polymerase inhibitor, A1/2/3 adenosine modulator.

More Information Supplier Page

Clofarabine 25 mg  | ≥98%

LKT Laboratories, Inc.

Nucleoside (adenosine) analog; DNA chain terminator, ribonucleotide reductase and DNA polymerase inhibitor, A1/2/3 adenosine modulator.

More Information Supplier Page

Clofarabine 100 mg  | ≥98%

LKT Laboratories, Inc.

Nucleoside (adenosine) analog; DNA chain terminator, ribonucleotide reductase and DNA polymerase inhibitor, A1/2/3 adenosine modulator.

More Information Supplier Page

Clozapine 250 mg  | ≥97%

LKT Laboratories, Inc.

M4 mAChR agonist, 5-HT1A partial agonist, M1/2/3/5 mAChR, D2 antagonist, Kv1.1 K+ channel blocker.

More Information Supplier Page

Clozapine 25 mg  | ≥97%

LKT Laboratories, Inc.

M4 mAChR agonist, 5-HT1A partial agonist, M1/2/3/5 mAChR, D2 antagonist, Kv1.1 K+ channel blocker.

More Information Supplier Page